Strawberry Production in Central Europe

Abstract

This paper focuses on the cropping systems in central European countries such as Belgium, The Netherlands, UK, Ireland, Germany, Switzerland and the northern part of France and Italy. During the last decade there has been a consistent increase in programmed “out-of-season” strawberry production in several central European countries. This is being achieved in part, by using cultivars with different cropping seasons, but mainly by sequential planting of cold-stored plants and by growing strawberries in greenhouses and plastic tunnels. These methods have made it possible to extend the strawberry production for 11 months, from the end of February until mid January in central European countries with moderate climates.     

过表达NR4A1促进山羊皮下脂肪细胞分化

旨在克隆山羊NR4A1基因的CDS区序列,明确其组织和细胞表达模式,以及探究过表达NR4A1基因对山羊皮下脂肪细胞分化的影响。本试验利用双酶切法构建山羊过表达载体pcDNA3.1-NR4A1。以1周岁简州大耳羊（n=5）为试验动物。利用RT-PCR方法和实时荧光定量PCR（real-time quantitative PCR, qPCR）技术克隆NR4A1基因编码区序列并明确其时空表达特性,再将山羊pcDNA3.1-NR4A1载体转染皮下脂肪细胞使NR4A1过表达,利用形态学方法检测过表达后脂滴聚集的变化,同时采用qPCR方法检测脂肪分化标志基因相对表达水平的变化。结果获得山羊NR4A1基因的编码区序列是1 797 bp,编码598个氨基酸;NR4A1在山羊各组织中广泛表达,且在山羊背最长肌中的相对表达水平最高（P<0.01）,在山羊皮下脂肪细胞分化60 h表达量最高（P<0.01）;过表达NR4A1基因显著促进山羊皮下脂肪细胞的脂滴积累,并且显著提高C/EBPα、C/EBPβ、PPARγ、LPL、SREBP1和AP2的相对表达水平（P<0.05）。NR4A1基因可能是山羊皮下脂肪细胞分化的正调控因子,且可能是协同脂肪分化标志基因的表达量来实现的。     

交叉中和血清1型和血清3型鸭甲肝病毒单克隆抗体的制备与鉴定

鸭甲型肝炎（duck hepatitis A,DHA）是危害养鸭业的主要疾病之一,是一种雏鸭的急性、高度致死性传染病。本研究旨在研制一种对我国流行的鸭甲型肝炎血清1型（DHAV-1）和血清3型（DHAV-3）病毒具有交叉中和作用的单克隆抗体（monoclonal antibody,McAb）。人工合成12条DHAV-1和DHAV-3的VP1蛋白共有的抗原表位肽,分别与钥孔血蓝蛋白（keyhole limpet hemocyanin,KLH）载体偶联作为免疫抗原,免疫BALB/c小鼠制备McAb。通过检测McAb与DHAV-1和DHAV-3的交叉反应性,测定McAb对病毒增殖的抑制效率、中和效价以及攻毒保护率等来筛选McAb。本研究共获得了12株稳定分泌McAb的杂交瘤细胞株,其中6株（C1、C4、C7、C12、C13、C16）分泌的McAb同时与DHAV-1和DHAV-3发生特异性交叉反应; C1、C4、C7、C16可以抑制DHAV-1和DHAV-3在鸭胚中的增殖,抑制率在75.34%～100.00%不等;对DHAV-1和DHAV-3的中和效价：C1（1：3&1：5）、C4（1：3&1：3）、C7（1：10&1：11）和C16（1：9&1：9）;C7和C16对DHAV-1和DHAV-3攻毒雏鸭的保护率较高,分别为“70%、80%”和“100%、60%”。本研究成功研制出对DHAV-1和DHAV-3具有交叉中和活性的McAb 4株,其中2株对病毒的感染具有良好的预防效果,为DHA的防控提供了新材料和新思路。     

Genetics of equine bleeding disorders

Genetic bleeding disorders can have a profound impact on a horse's health and athletic career. As such, it is important to understand the mechanisms of these diseases and how they are diagnosed. These diseases include haemophilia A, von Willebrand disease, prekallikrein deficiency, Glanzmann's Thrombasthenia and Atypical Equine Thrombasthenia. Exercise-induced pulmonary haemorrhage also has a proposed genetic component. Genetic mutations have been identified for haemophilia A and Glanzmann's Thrombasthenia in the horse. Mutations are known for von Willebrand disease and prekallikrein deficiency in other species. In the absence of genetic tests, bleeding disorders are typically diagnosed by measuring platelet function, von Willebrand factor, and other coagulation protein levels and activities. For autosomal recessive diseases, genetic testing can prevent the breeding of two carriers.     

Altered vitamin D metabolic system in follicular cysts of sows

This study aimed to examine 25OHD₃ concentration in the fluid of follicular and follicular lutein cysts of sows in comparison with preovulatory follicles as well as immunolocalize vitamin D metabolic enzymes (CYP27B1 and CYP24A1) and determine their protein abundances in the cyst wall. We have shown for the first time that 25OHD₃ level in the fluid of both cyst types was significantly lower than in preovulatory follicles. Furthermore, we have demonstrated CYP27B1 and CYP24A1 protein immunolocalization and abundance in follicular and follicular lutein cysts. The abundance of protein for both metabolic enzymes was decreased in ovarian cysts when compared to preovulatory follicles. We propose that altered VD metabolism in ovarian cyst might associate with their formation in sows.     

口蹄疫病毒A型竞争ELISA抗体检测试剂盒在流行病学调查中的应用

为评价口蹄疫病毒A型竞争ELISA(cELISA)抗体检测试剂盒在流行病学调查中的应用前景,对2017年从福建省三明市采集的336份黄牛、奶牛、羊和猪血清样品,用A型cELISA抗体检测试剂盒进行抗体检测。结果显示,92份黄牛血清、92份羊血清、92份猪血清、60份奶牛血清的A型抗体阳性率分别为13.04%、11.96%、20.65%、86.67%。从上述4种血清中,各挑选10份血清(阴性、阳性各5份)共40份,采用口蹄疫病毒液相阻断ELISA(LPB-ELISA)抗体检测试剂盒进行验证。结果显示:cELISA检测为阳性的20份血清中,用LPB-ELISA检出阳性19份;cELISA检测为阴性的20份血清中,用LPB-ELISA检出阴性17份;两种方法的κ值为0.8,总符合率为90.00%。结果表明,A型cELISA试剂盒与LPB-ELISA试剂盒的符合率和一致性均较高,可用于口蹄疫流行病学调查和血清学监测。     

双表达去势DNA疫苗的构建及其稳定性研究

试验旨在构建一种更安全有效的新型免疫去势DNA疫苗,通过选取下丘脑-垂体-性腺轴（hypot halamic-pituitary-gonadal axis,HPG）的上游调控基因吻素1（KISS1）和促性腺激素释放激素（GnRH）作为靶标,借助2A肽的自剪切功能,引入平衡致死系统代替抗性基因筛选流程,成功将GnRH和KISS1转入非抗性筛选质粒pVAX-asd中,酶切验证和测序对比验证目的基因的插入方向和序列完全正确。重组质粒转染HeLa细胞,反转录后扩增目的基因结果显示,重组质粒在真核细胞内能够正常转录,保证重组质粒在导入机体后能够正常表达,从而引起特异性免疫反应。将构建成功的质粒转入减毒的猪霍乱沙门氏菌C500中,获得可直接口服免疫的活载体疫苗,酶切和测序结果表明,双表达重组质粒成功导入工程菌中。将活菌疫苗在体外连续传代50次,选取0、2、5、10、20、30、40、50代的菌株进行稳定性研究,生长曲线检测结果表明,工程菌在体外连续传代50次的过程中,其生长特性无明显变化,且与减毒猪霍乱沙门氏菌C500的生长特性一致,未因携带质粒发生明显变化;同时将各代菌液扩增沙门氏菌标志基因（invA）和毒力基因（crp）,结果表明多次传代后工程菌仍然具有沙门氏菌的特性,其减毒特性也无变化。各代菌液质粒酶切验证显示,多次传代并不影响质粒的稳定性,重组双表达质粒能够在沙门氏菌C500中维持正常拷贝功能。综上所述,该重组质粒和工程菌疫苗均具有良好的稳定性,可直接应用于动物免疫去势的研究。